[Sulindac induced apoptosis of HT-29 colon adenocarcinoma cell]

This study was intended to examine whether sulindac induces apoptosis in the HT-29 cells. Flow cytometry, transmission electron microscopy and DNA electrophoresis were used. Flow cytometry, transmission electron microscopy and DNA electrophoresis all demonstrated that sulindac could induce apoptosis of the HT-29 cell line in a time- and dose-dependent manner. After treatment with 0.3 mmol/L, 0.6 mmol/L and 1.2 mmol/L sulindac for 48 hours, apoptotic cells in the treatment groups reached 5.8%, 7.6% and 11.7% versus 2.9% in the control group; after treatment for 72 hours, apoptotic cells in the treatment groups increased to 12.5%, 15.4% and 24.4% versus 5.1% in the control group, respectively, P < 0.05. This study has demonstrated that colon adenocarcinoma HT-29 cell line can be induced by sulindac.